Arginine vasopressin controls p27(KiP1) protein expression by PKC activation and irreversibly inhibits the proliferation of K-Ras-dependent mouse Y1 adrenocortical malignant cells


Autoria(s): FORTI, Fabio L.; ARMELIN, Hugo A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2011

Resumo

The neurohypophyseal hormone arginine vasopressin (AVP) is a classic mitogen in many cells. In K-Ras-dependent mouse Y1 adrenocortical malignant cells, AVP elicits antagonistic responses such as the activation of the PKC and the ERK1/2 mitogenic pathways to down-regulate cyclin D1 gene expression, which induces senescence-associated beta-galactosidase (SA-beta Gal) and leads to cell cycle arrest. Here, we report that in the metabolic background of Y1 cells, PKC activation either by AVP or by PMA inhibits the PI3K/Akt pathway and stabilises the p27(Kip1) protein even in the presence of the mitogen fibroblast growth factor 2 (FGF2). These results suggest that p27(Kip1) is a critical signalling node in the mechanisms underlying the survival of the Y1 cells. In Y1 cells that transiently express wild-type p27(Kip1), AVP caused a severe reduction in cell survival, as shown by clonogenic assays. However, AVP promoted the survival of Y1 cells transiently expressing mutant p27-S10A or mutant p27-T187A, which cannot be phosphorylated at Ser10 and Thr187, respectively. In addition, PKC activation by PMA mimics the toxic effect caused by AVP in Y1 cells, and inhibition of PKC completely abolishes the effects caused by both PMA and AVP in clonogenic assays. The vulnerability of Y1 cells during PKC activation is a phenotype conditioned upon K-ras oncogene amplification because K-Ras down-regulation with an inducible form of the dominant-negative mutant H-RasN17 has resulted in Y1 cells that are resistant to AVP`s deleterious effects. These data show that the survival destabilisation of K-Ras-dependent Y1 malignant cells by AVP requires large quantities of the p27(Kip1) protein as well as phosphorylation of the p27(Kip1) protein at both Ser10 and Thr187. (C) 2011 Elsevier B.V. All rights reserved.

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Sao Paulo Research Foundation, Fapesp[08/58264-5]

Sao Paulo Research Foundation, Fapesp[08/51273-9]

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

National Council for Scientific and Technological Development, CNPq[475488/2008-3]

Identificador

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, v.1813, n.8, p.1438-1445, 2011

0167-4889

http://producao.usp.br/handle/BDPI/30999

10.1016/j.bbamcr.2011.04.007

http://dx.doi.org/10.1016/j.bbamcr.2011.04.007

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE BV

Relação

Biochimica Et Biophysica Acta-molecular Cell Research

Direitos

restrictedAccess

Copyright ELSEVIER SCIENCE BV

Palavras-Chave #Arginine vasopressin #p27(Kip1) #Mouse Y1 adrenocortical cells #K-Ras #Protein kinase C #CYCLIN D1 #TUMOR SUPPRESSION #MICE LACKING #HUMAN CANCER #LUNG-CANCER #GENE #PATHWAY #GROWTH #RECEPTORS #TUMORIGENESIS #Biochemistry & Molecular Biology #Cell Biology
Tipo

article

original article

publishedVersion